CFP
GILD icon

Catalyst Financial Partners’s Gilead Sciences GILD Stock Holding History

Catalyst Financial Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$722K Buy
5,716
+241
+4% +$31.8K 0.07% 158
2026
Q1 		$763K Buy
5,475
+636
+13% +$89.1K 0.09% 135
2025
Q4 		$594K Buy
4,839
+132
+3% +$16K 0.07% 153
2025
Q3 		$522K Buy
4,707
+190
+4% +$21.6K 0.06% 160
2025
Q2 		$501K Buy
4,517
+508
+13% +$54.1K 0.05% 165
2025
Q1 		$449K Buy
4,009
+238
+6% +$24.6K 0.08% 164
2024
Q4 		$348K Sell
3,771
-1,564
-29% -$141K 0.07% 186
2024
Q3 		$447K Buy
5,335
+421
+9% +$32.1K 0.09% 149
2024
Q2 		$337K Buy
4,914
+562
+13% +$37.5K 0.07% 170
2024
Q1 		$291K Sell
4,352
-798
-15% -$61.4K 0.07% 173
2023
Q4 		$417K Buy
5,150
+261
+5% +$20.3K 0.12% 116
2023
Q3 		$366K Buy
4,889
+298
+6% +$22.9K 0.12% 129
2023
Q2 		$354K Buy
4,591
+557
+14% +$44.4K 0.13% 118
2023
Q1 		$335K Buy
4,034
+355
+10% +$29.4K 0.14% 111
2022
Q4 		$316K Buy
+3,679
New +$291K 0.16% 101

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Catalyst Financial Partners's GILD Position: Q2 2026 in Review

Catalyst Financial Partners increased its Gilead Sciences (GILD) stake by 4.4% in Q2 2026, buying an estimated $31.8K and bringing the position to 5,716 shares worth $722K. The position accounts for 0.07% of the portfolio, ranked #158.

Catalyst Financial Partners first reported a position in GILD in Q4 2022 and has held it in 15 quarters since. The position peaked at $763K in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Catalyst Financial Partners held 5,716 shares of Gilead Sciences worth $722K as of Q2 2026.
  • Catalyst Financial Partners bought 241 Gilead Sciences shares in Q2 2026, an estimated $31.8K.
  • Gilead Sciences made up 0.07% of Catalyst Financial Partners's portfolio in Q2 2026, its #158 holding.
  • Catalyst Financial Partners first reported a position in Gilead Sciences in Q4 2022 and has held it in 15 quarters since.
  • Catalyst Financial Partners's Gilead Sciences position peaked at $763K in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Catalyst Financial Partners's 13F filing for Q2 2026, filed 30 Jul 2026.